We are live on ! Find out more
AEMD icon

Aethlon Medical

11 hedge funds and large institutions have $684K invested in Aethlon Medical in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more funds holding

Funds holding: 611 (+5)

56% more capital invested

Capital invested by funds: $437K → $684K (+$247K)

0% more ownership

Funds ownership: 0%0% (+0%)

Holders
11
Holders Change
+5
Holders Change %
+83.33%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q3 2017 in Review

11 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2017, worth a combined $684K — up 56% from $437K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new AEMD positions and 0 closed out — a net gain of 5 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, adding an estimated $258K. The largest seller was D.A. Davidson & Co, cutting an estimated $3K.

  • 11 institutional investors held Aethlon Medical (AEMD) as of Q3 2017, up from 6 in Q2 2017.
  • Funds reported $684K of Aethlon Medical stock for Q3 2017, up 56% quarter-over-quarter.
  • 5 funds opened new Aethlon Medical positions in Q3 2017 and 0 closed out, a net change of +5 holders.
  • The largest Aethlon Medical buyer in Q3 2017 was Vanguard Group, an estimated $258K added.
  • The largest Aethlon Medical seller in Q3 2017 was D.A. Davidson & Co, an estimated $3K sold.

Based on aggregated 13F filings for Q3 2017.